When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PTI - Proteostasis to initiate personalized CF study in Europe; shares up 17% premarket
Yumanity Therapeutics Inc Com
Proteostasis Therapeutics (NASDAQ:PTI) announces positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance regulator (CFTR) modulators, PTI-801, PTI-808, and PTI-428, in individuals with cystic fibrosis (CF) who are ineligible for the current standard of care due to their genotype.
More news on: Proteostasis Therapeutics, Inc., Healthcare stocks news, Stocks on the move,